Pooled evidence from 2 randomized trials and 6 observational cohorts suggests posttransplant gilteritinib maintenance may ...
LENA Platform's four LDT products detect leukemia up to 41 months before symptoms — now live at alercell.com Alercell ...
PARADIGM data suggest azacitidine plus venetoclax improves AML event-free survival vs 7+3 with less toxicity; survival looks ...
For adults with acute myeloid leukemia (AML), pretransplant NPM1 measurable residual disease (MRD) is prognostic for relapse, ...
NEWS10 ABC on MSN
Marking a milestone: Capital Region baby with rare disease turns 1
MALTA, N.Y. (NEWS10) — A child’s first birthday is a major milestone for any parent, but for one couple in the Capital Region ...
A new study found that eating more meat was linked to better cognitive outcomes in people with a genetic risk for Alzheimer’s ...
More than 50 years after Agent Orange was used in Vietnam, a new national study published online ahead of print in Blood ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Blood Cancer United® (formerly The Leukemia & Lymphoma Society), the largest global ...
Persistent insomnia and night sweats may sometimes signal cancer, though they often have common causes. Experts say these ...
Across treatment classes, CH associated with increased therapy-related cytopenias, particularly neutropenia, and DNMT3A/TET2 ...
Although survival rates for acute myeloid leukemia (AML) continue to improve, many long-term survivors face persistent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results